Literature DB >> 17470448

Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.

Kathleen M McCarty1, Thomas J Smith, Wei Zhou, Ernesto Gonzalez, Quazzi Quamruzzaman, Mahmuder Rahman, Golam Mahiuddin, Louise Ryan, Li Su, David C Christiani.   

Abstract

BACKGROUND: Single-nucleotide polymorphisms in genes related to DNA repair capacity and ultraviolet exposure have not been well investigated in relation to skin lesions associated with arsenic exposure. This population based case-control study, of 600 cases and 600 controls, frequency matched on age and gender in Pabna, Bangladesh, in 2001-2002, investigated the association and potential effect modification between polymorphisms in Xeroderma Pigmentosum complementation group D (XPD) (Lys751Gln and Asp312Asn) genes, tendency to sunburn and arsenic-related skin lesions.
METHODS: Unconditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). RESULT: No significant association was observed between skin lesions and the XPD 312 Asp/Asn (adjusted OR = 0.87, 95% CI = 0.65-1.15) Asn/Asn (adjusted OR = 0.76, 95% CI = 0.50-1.15) (referent Asp/Asp); XPD 751 Lys/Gln (adjusted OR = 0.92, 95% CI = 0.69-1.23) Gln/Gln (adjusted OR = 0.98, 95% CI = 0.66-1.45) (referent Lys/Lys). While we did not observe any evidence of effect modification of these polymorphisms on the association between well arsenic concentration and skin lesions, we did observe effect modification between these polymorphisms and sunburn tendency and arsenic-related skin lesions. Individuals with the heterozygote or homozygote variant forms (Asp/Asn or Asn/Asn) had half the risk of skin lesions (OR = 0.45, 95% CI = 0.29-0.68) compared with those with the wild-type XPDAsp312Asn genotype (Asp/Asp) and individuals with heterozygote or homozygote variant forms (Lys/Gln or Gln/Gln) had half the risk of skin lesions (OR = 0.47, 95% CI = 0.31-0.72) compared with those with the wild-type XPDLys751Gln genotype (Lys/Lys), within the least sensitive strata of sunburn severity. We observed effect modification on the multiplicative scale for XPD 751 and XPD 312.
CONCLUSION: XPD polymorphisms modified the relationship between tendency to sunburn and skin lesions in an arsenic exposed population. Further study is necessary to explore the effect of XPD polymorphisms and sun exposure on risk of arsenic-related skin lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470448      PMCID: PMC3879118          DOI: 10.1093/carcin/bgm099

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  45 in total

1.  XPD polymorphisms: effects on DNA repair proficiency.

Authors:  R M Lunn; K J Helzlsouer; R Parshad; D M Umbach; E L Harris; K K Sanford; D A Bell
Journal:  Carcinogenesis       Date:  2000-04       Impact factor: 4.944

2.  Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells.

Authors:  E J Duell; J K Wiencke; T J Cheng; A Varkonyi; Z F Zuo; T D Ashok; E J Mark; J C Wain; D C Christiani; K T Kelsey
Journal:  Carcinogenesis       Date:  2000-05       Impact factor: 4.944

3.  Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh.

Authors:  Yu Chen; Joseph H Graziano; Faruque Parvez; Iftikhar Hussain; Hassina Momotaj; Alexander van Geen; Geoffrey R Howe; Habibul Ahsan
Journal:  Epidemiology       Date:  2006-07       Impact factor: 4.822

Review 4.  The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases.

Authors:  A R Lehmann
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

5.  Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations.

Authors:  Mayukh Banerjee; Jyotirmoy Sarkar; Jayanta K Das; Angshuman Mukherjee; Ajoy K Sarkar; Lakshmikanta Mondal; Ashok K Giri
Journal:  Carcinogenesis       Date:  2006-10-17       Impact factor: 4.944

Review 6.  Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.

Authors:  K T Kitchin
Journal:  Toxicol Appl Pharmacol       Date:  2001-05-01       Impact factor: 4.219

Review 7.  XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.

Authors:  Maurizio Manuguerra; Federica Saletta; Margaret R Karagas; Marianne Berwick; Fabrizio Veglia; Paolo Vineis; Giuseppe Matullo
Journal:  Am J Epidemiol       Date:  2006-05-17       Impact factor: 4.897

8.  The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice.

Authors:  K Yamanaka; K Katsumata; K Ikuma; A Hasegawa; M Nakano; S Okada
Journal:  Cancer Lett       Date:  2000-04-28       Impact factor: 8.679

9.  Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions.

Authors:  Kathleen M McCarty; Yen-Ching Chen; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Yu-Mei Hsueh; Li Su; Thomas Smith; Louise Ryan; David C Christiani
Journal:  Environ Health Perspect       Date:  2006-12-20       Impact factor: 9.031

10.  One solution to the arsenic problem: a return to surface (improved dug) wells.

Authors:  Sakila Afroz Joya; Golam Mostofa; Jabed Yousuf; Ariful Islam; Altab Elahi; Golam Mahiuddin; Mahmuder Rahman; Quazi Quamruzzaman; Richard Wilson
Journal:  J Health Popul Nutr       Date:  2006-09       Impact factor: 2.000

View more
  6 in total

1.  Arsenic geochemistry and human health in South East Asia.

Authors:  Kathleen M McCarty; Hoang Thi Hanh; Kyoung-Woong Kim
Journal:  Rev Environ Health       Date:  2011       Impact factor: 3.458

2.  Association of genetic variation in cystathionine-beta-synthase and arsenic metabolism.

Authors:  Kristin E Porter; Anamika Basu; Alan E Hubbard; Michael N Bates; David Kalman; Omar Rey; Allan Smith; Martyn T Smith; Craig Steinmaus; Christine F Skibola
Journal:  Environ Res       Date:  2010-06-01       Impact factor: 6.498

Review 3.  Individual susceptibility to arsenic-induced diseases: the role of host genetics, nutritional status, and the gut microbiome.

Authors:  Liang Chi; Bei Gao; Pengcheng Tu; Chih-Wei Liu; Jingchuan Xue; Yunjia Lai; Hongyu Ru; Kun Lu
Journal:  Mamm Genome       Date:  2018-02-10       Impact factor: 2.957

4.  Functional polymorphisms in XRCC-1 and APE-1 contribute to increased apoptosis and risk of ulcerative colitis.

Authors:  Avinash Bardia; Santosh K Tiwari; Sivaram Gunisetty; Farha Anjum; Pratibha Nallari; Md Aejaz Habeeb; Aleem A Khan
Journal:  Inflamm Res       Date:  2011-12-23       Impact factor: 4.575

Review 5.  Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.

Authors:  Feifan Xiao; Jian Pu; Qiongxian Wen; Qin Huang; Qinle Zhang; Birong Huang; Shanshan Huang; Aihua Lan; Yuening Zhang; Jiatong Li; Dong Zhao; Jing Shen; Huayu Wu; Yan He; Hongtao Li; Xiaoli Yang
Journal:  Oncotarget       Date:  2017-07-18

6.  GYY4137 Attenuates Sodium Deoxycholate-Induced Intestinal Barrier Injury Both In Vitro and In Vivo.

Authors:  Zeyang Chen; Jianqiang Tang; Pengyuan Wang; Jing Zhu; Yucun Liu
Journal:  Biomed Res Int       Date:  2019-10-13       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.